Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Systemic Lupus Erythematosus Research, and Monoclonal and Polyclonal Antibodies Research.
The CD5-CK2-STAT3 axis in Th17 cell polarization: implications for multiple sclerosis.
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
Clinical and serological associations of interferon-α and interferon-γ in rheumatoid arthritis patients.
Apheresis CD8<sup>+</sup>CCR7<sup>+</sup>CD45RA<sup>-</sup> T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.
Smartphone Keystroke Monitoring to Predict Progression Independent of Relapse in Multiple Sclerosis: A machine-learning-based evaluation (Preprint)
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile.
Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis.
Attitudes of Neurologists Toward Serum Neurofilament Light-Chain Testing in the Management of Relapsing-Remitting Multiple Sclerosis with Cognitive Impairment.
Ultrasensitive quantification of serum IFN-α and IFN-γ in systemic lupus erythematosus: A cross-sectional observational study.
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis.
Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults.
MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention.
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis
Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis.
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis.
Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis.
Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients.
Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers.
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure.
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine.
Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non-cell-autonomous neuronal damage.
Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study.
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis.
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.